Catalyst Wire Dossier Catalyst Wire Dossier

IMVAMUNE (MVA-BN)

MVA-BN · Bavarian Nordic
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IMVAMUNE (MVA-BN), covering 2019-01-10 to 2020-10-12. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects [Phase 2]

See pricing